Abstract:Purpose: Asymmetric dimethylarginine (ADMA), an endogenous competitive inhibitor of nitric oxide synthase, is associated with impaired endothelial dysfunction, such as chronic heart failure, hypertension, diabetes, and pulmonary hypertension. The effects of ADMA on cell proliferation, reactive oxygen species (ROS) production, cell permeability, intercellular adhesion molecule-1 (ICAM-1), and tight-junction protein occludin levels in bovine retinal capillary endothelial cells (BRCECs) were investigated.Methods: A cell proliferation assay was performed using the novel tetrazolium compound 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium and an electron coupling reagent. Intracellular ROS levels were determined using the fluorescent probe CM-H(2)DCFDA. Horseradish peroxidase was used for a permeability assay. ICAM-1 and tight-junction protein occludin were assessed by western blotting and quantitative real-time PCR.Results: Cell proliferation was significantly inhibited by ADMA. ADMA increased intracellular ROS generation in BRCECs. The increased ROS production induced by ADMA was markedly inhibited by the angiotensin II receptor-blocker telmisartan, the angiotensin-converting enzyme inhibitor benazepril, the reduced form of nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase inhibitor diphenyliodonium (DPI), or the antioxidant and free-radical scavenger N-acetyl-L-cysteine (NAC). ADMA significantly increased horseradish peroxidase (HRP) permeability in BRCECs. Benazepril, telmisartan, DPI, and NAC downregulated cell permeability. ADMA markedly upregulated ICAM-1 expression in BRCECs, which were downregulated by telmisartan, DPI, and NAC. ADMA significantly downregulated occludin expression in BRCECs. Benazepril and telmisartan upregulated occludin expression in BRCECs exposed to ADMA.Conclusions: Our results provide the first reported evidence that ADMA has potent adverse effects on cell proliferation, intracellular ROS generation, cell permeability, levels of ICAM-1, and the tight-junction protein occludin. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and antioxidants are effective inhibitors of the adverse effects of ADMA.

Actin cytoskeleton modulates ADMA-induced NF-kappaB nuclear translocation and ICAM-1 expression in endothelial cells.

Actin Cytoskeleton-Dependent Pathways for ADMA-induced NF-κB Activation and TGF-β High Expression in Human Renal Glomerular Endothelial Cells.

Disruption of Asymmetric Dimethylarginine-Induced Rela/P65 Association with Actin in Endothelial Cells

The Mechanism of Long-Term Low-Dose Asymmetric Dimethylarginine Inducing Transforming Growth Factor-Β Expression in Endothelial Cells.

Effects of Antioxidants and Nitric Oxide on TNF-α-induced Adhesion Molecule Expression and NF-κB Activation in Human Dermal Microvascular Endothelial Cells

Asymmetric dimethylarginine damages connexin43-mediated endothelial gap junction intercellular communication.

Asymmetric Dimethylarginine Impairs Fibrinolytic Activity in Human Umbilical Vein Endothelial Cells Via P38 MAPK and NF-κB Pathways.

Activation of endothelial nitric oxide synthase is dependent on its interaction with globular actin in human umbilical vein endothelial cells

The Inhibitory Effect of Simvastatin on the ADMA-induced Inflammatory Reaction is Mediated by MAPK Pathways in Endothelial Cells.

Adma Induces Monocyte Adhesion Via Activation of Chemokine Receptors in Cultured Thp-1 Cells

Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of l-arginine on its metabolism

[Effect of Asymmetric Dimethylarginine on the Activation of Hepatic Stellate Cells and Its Mechanism].

Asymmetric Dimethylarginine Induces Apoptosis Via P38 MAPK/caspase-3-dependent Signaling Pathway in Endothelial Cells

Dimethylarginine Dimethylaminohydrolase 1 Modulates Endothelial Cell Growth Through Nitric Oxide and Akt

Study on inhibitory effect of reinioside C on asymmetric dimethylanginine-induced soluble interacellular adhesion molecule-1 expression and its mechanisms

Role of Asymmetric Dimethylarginine in Inflammatory Reactions by Angiotensin Ii

Role of the p38 MAPK signaling pathway in asymmetric dimethylarginine induced increase in endothelial permeability

Exogenous, but not Endogenous Nitric Oxide Inhibits Adhesion Molecule Expression in Human Endothelial Cells

Relations Between Plasma Asymmetric Dimethylarginine (adma) and Risk Factors for Coronary Disease

Effects of Asymmetric Dimethylarginine on Bovine Retinal Capillary Endothelial Cell Proliferation, Reactive Oxygen Species Production, Permeability, Intercellular Adhesion Molecule-1, and Occludin Expression

Asymmetric Dimethylarginine Induces Tissue Factor Expression in Monocytes Via NF-kappaB-dependent Pathway: Role in Acute Coronary Syndromes